about
SCN4A mutation as modifying factor of myotonic dystrophy type 2 phenotype.NEU3 sialidase is activated under hypoxia and protects skeletal muscle cells from apoptosis through the activation of the epidermal growth factor receptor signaling pathway and the hypoxia-inducible factor (HIF)-1αA chemical approach to myocardial protection and regeneration.High-sensitive cardiac troponin T (hs-cTnT) assay as serum biomarker to predict cardiac risk in myotonic dystrophy: A case-control study.NEU3 Sialidase Protein Interactors in the Plasma Membrane and in the Endosomes.Gangliosides as a potential new class of stem cell markers: the case of GD1a in human bone marrow mesenchymal stem cells.Potent Inhibitors against Newcastle Disease Virus Hemagglutinin-Neuraminidase.NEU3 sialidase role in activating HIF-1α in response to chronic hypoxia in cyanotic congenital heart patients.Activation of the hypoxia-inducible factor 1α promotes myogenesis through the noncanonical Wnt pathway, leading to hypertrophic myotubes.Synthesis and biological evaluation of several dephosphonated analogues of CMP-Neu5Ac as inhibitors of GM3-synthase.NEU4L sialidase overexpression promotes β-catenin signaling in neuroblastoma cells, enhancing stem-like malignant cell growth.Glycoglycerolipid analogues inhibit PKC translocation to the plasma membrane and downstream signaling pathways in PMA-treated fibroblasts and human glioblastoma cells, U87MG.Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing StrategiesGM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem CellsSingle-shot morpho-functional and structural characterization of the left-ventricle in a mouse model of acute ischemia-reperfusion injury with an optimized 3D IntraGate cine FLASH sequence at 7T MRSynthesis and chemical characterization of several perfluorinated sialic acid glycals and evaluation of their in vitro antiviral activity against Newcastle disease virusLactonization Method To Assign the Anomeric Configuration of the 3,4-Unsaturated Congeners of N-Acetylneuraminic Acid
P50
Q38912053-4A7980C4-0354-4B17-8DA6-D1F72FA945D2Q39233050-2596D196-D5F6-416C-A440-CA9BC89DEA13Q39323701-3DE4E571-B903-4654-8D8A-FB03CB015092Q40491799-2C13936F-F309-4AA7-AD30-24EC46768397Q41510497-7E1FF060-A955-4B80-A16F-1DD0642BE2C4Q41978112-E35C4391-A56C-4C1E-B2DC-980F07EFA882Q47258821-E8350FA0-7169-42A4-9B67-FE45DC6DE0B0Q50980874-C2DF21BD-9BE4-481E-BFA6-9FEBC4124275Q51008908-2EBD64BC-63B6-42AC-A790-856E6E6833D9Q51710814-EA9F65EF-A044-41B2-9806-89F7D6F928EDQ53189212-F9E83DE7-E732-4A70-9614-448E5A778280Q54606036-1F87CC79-F6E3-42DA-A8BB-2586336F4D0FQ58555709-C722EABC-ABCC-4900-9D7D-7650788905B4Q58711718-56D8A545-403C-4BC7-A924-96A032A94642Q89468827-91EE058E-55F3-4458-81E7-9E5F90D83FFAQ90950142-D4340F96-6A76-44C0-BF3A-C511D7CB55B3Q92502014-711CF297-13AD-48E9-B1D5-D60997A45D53
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Federica Cirillo
@ast
Federica Cirillo
@en
Federica Cirillo
@es
Federica Cirillo
@nl
Federica Cirillo
@sl
type
label
Federica Cirillo
@ast
Federica Cirillo
@en
Federica Cirillo
@es
Federica Cirillo
@nl
Federica Cirillo
@sl
prefLabel
Federica Cirillo
@ast
Federica Cirillo
@en
Federica Cirillo
@es
Federica Cirillo
@nl
Federica Cirillo
@sl
P106
P1153
35893194000
P21
P31
P496
0000-0002-0196-5977